Page last updated: 2024-11-02

pamidronate and Esophagitis

pamidronate has been researched along with Esophagitis in 2 studies

Esophagitis: INFLAMMATION, acute or chronic, of the ESOPHAGUS caused by BACTERIA, chemicals, or TRAUMA.

Research Excerpts

ExcerptRelevanceReference
"Pamidronate (aminohydroxypropylidine bisphosphonate, APD) is an effective agent for treatment of Paget's disease of bone, and it has also been thought to be effective for treatment of osteoporosis."5.07Pamidronate: an unrecognized problem in gastrointestinal tolerability. ( Argueta, R; Cameron, AL; Egan, KS; Lufkin, EG; O'Fallon, WM; Riggs, BL; Whitaker, MD; Wong, VH, 1994)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akhtar, J1
Gorantla, VK1
Snell, PD1
Wall, BM1
Lufkin, EG1
Argueta, R1
Whitaker, MD1
Cameron, AL1
Wong, VH1
Egan, KS1
O'Fallon, WM1
Riggs, BL1

Trials

1 trial available for pamidronate and Esophagitis

ArticleYear
Pamidronate: an unrecognized problem in gastrointestinal tolerability.
    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 1994, Volume: 4, Issue:6

    Topics: Aged; Diphosphonates; Esophagitis; Esophagoscopy; Female; Humans; Middle Aged; Osteoporosis; Pamidro

1994

Other Studies

1 other study available for pamidronate and Esophagitis

ArticleYear
Acute esophageal necrosis (black esophagus) complicating calcific uremic arteriolopathy
.
    Clinical nephrology, 2019, Volume: 91, Issue:1

    Topics: Acute Disease; Aged; Arterioles; Bone Density Conservation Agents; Esophagitis; Esophagoscopy; Esoph

2019